Crossmark

Kidney and cardiovascular-protective benefits of combination drug therapies in chronic kidney disease associated with type 2 diabetes

Published Online: 2024-08-01

Authors

Khan, Muhammad Shahzeb

Lea, Janice P.
License Information

Text and Data Mining valid from 2024-08-01

Version of Record valid from 2024-08-01
More Information

Article History

Received: 8 February 2024

Accepted: 24 June 2024

First Online: 1 August 2024

Declarations

:

: Not applicable.

: No applicable.

: Muhammad Shahzeb Khan and Janice Lea are both Bayer advisory board members.

Document is current